144 related articles for article (PubMed ID: 29228568)
1. Sitagliptin and oral cancer risk in type 2 diabetes patients.
Tseng CH
Oncotarget; 2017 Nov; 8(57):96753-96760. PubMed ID: 29228568
[TBL] [Abstract][Full Text] [Related]
2. Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes.
Tseng CH
Oncotarget; 2017 Mar; 8(12):19057-19064. PubMed ID: 27661113
[TBL] [Abstract][Full Text] [Related]
3. Sitagliptin use and thyroid cancer risk in patients with type 2 diabetes.
Tseng CH
Oncotarget; 2016 Apr; 7(17):24871-9. PubMed ID: 27029076
[TBL] [Abstract][Full Text] [Related]
4. Sitagliptin and heart failure hospitalization in patients with type 2 diabetes.
Tseng CH
Oncotarget; 2016 Sep; 7(38):62687-62696. PubMed ID: 27409676
[TBL] [Abstract][Full Text] [Related]
5. Metformin and lung cancer risk in patients with type 2 diabetes mellitus.
Tseng CH
Oncotarget; 2017 Jun; 8(25):41132-41142. PubMed ID: 28456789
[TBL] [Abstract][Full Text] [Related]
6. Sitagliptin May Reduce Breast Cancer Risk in Women With Type 2 Diabetes.
Tseng CH
Clin Breast Cancer; 2017 Jun; 17(3):211-218. PubMed ID: 27986440
[TBL] [Abstract][Full Text] [Related]
7. Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.
Tseng CH
Oncotarget; 2017 Mar; 8(12):18802-18810. PubMed ID: 27861146
[TBL] [Abstract][Full Text] [Related]
8. Metformin and the Risk of Dementia in Type 2 Diabetes Patients.
Chin-Hsiao T
Aging Dis; 2019 Feb; 10(1):37-48. PubMed ID: 30705766
[TBL] [Abstract][Full Text] [Related]
9. Metformin use and cervical cancer risk in female patients with type 2 diabetes.
Tseng CH
Oncotarget; 2016 Sep; 7(37):59548-59555. PubMed ID: 27486978
[TBL] [Abstract][Full Text] [Related]
10. Sitagliptin and pancreatic cancer risk in patients with type 2 diabetes.
Tseng CH
Eur J Clin Invest; 2016 Jan; 46(1):70-9. PubMed ID: 26584246
[TBL] [Abstract][Full Text] [Related]
11. Metformin may reduce oral cancer risk in patients with type 2 diabetes.
Tseng CH
Oncotarget; 2016 Jan; 7(2):2000-8. PubMed ID: 26683519
[TBL] [Abstract][Full Text] [Related]
12. Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.
Tseng CH
Aging (Albany NY); 2016 Aug; 8(8):1636-49. PubMed ID: 27587088
[TBL] [Abstract][Full Text] [Related]
13. Metformin Decreases Risk of Tuberculosis Infection in Type 2 Diabetes Patients.
Tseng CH
J Clin Med; 2018 Sep; 7(9):. PubMed ID: 30205606
[TBL] [Abstract][Full Text] [Related]
14. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
Tseng CH
Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
[TBL] [Abstract][Full Text] [Related]
15. Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus.
Tseng CH
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439890
[TBL] [Abstract][Full Text] [Related]
16. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus.
Tseng CH
Sci Rep; 2021 Jun; 11(1):12400. PubMed ID: 34117321
[TBL] [Abstract][Full Text] [Related]
17. Sitagliptin increases acute pancreatitis risk within 2 years of its initiation: A retrospective cohort analysis of the National Health Insurance database in Taiwan.
Tseng CH
Ann Med; 2015; 47(7):561-9. PubMed ID: 26426676
[TBL] [Abstract][Full Text] [Related]
18. Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus.
Tseng CH
Metabolism; 2018 Aug; 85():223-226. PubMed ID: 29729227
[TBL] [Abstract][Full Text] [Related]
19. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
Tseng CH
Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
[TBL] [Abstract][Full Text] [Related]
20. Metformin use is associated with a lower risk of uterine leiomyoma in female type 2 diabetes patients.
Tseng CH
Ther Adv Endocrinol Metab; 2019; 10():2042018819895159. PubMed ID: 31897287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
